Navigation Links
Amarantus BioSciences Demands Cessation of Unauthorized Listing on Berlin-Bremen Stock Exchange
Date:11/26/2012

n of trading on the BBSE will have no impact whatsoever on trading in the Company's common stock on the OTCQB trading platform where the Company currently trades in the United States, and the Company's trading symbol in the United States will remain AMBS.

About JS Barkats, PLLC

JS Barkats PLLC is a dynamic full-service law firm headquartered in the heart of New York specializing in Corporate, Capital Markets and Securities law. JS Barkats, principally represents both established and publicly traded emerging growth companies, both domestic and foreign, in a wide variety of industries. With 22 attorneys located in Alabama, New York, and Florida the firm's synergy between its strong securities and commercial litigation group and its experienced corporate securities team, as well as an established IP department represents, public companies,  venture capital firms, start-ups, life sciences companies, investment banking institutions, broker dealers, celebrities and high net worth individuals and other investors. For more information visit: www.JSBarkats.com  

About Amarantus BioSciences, Inc.

Amarantus BioSciences, Inc. is a development-stage biotechnology company founded in January 2008.  The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, Traumatic Brain Injury and other human diseases.  The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. The Company also is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorder
'/>"/>

SOURCE Amarantus BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. OneMedPlace Releases Update to Research Report on Amarantus Biosciences Focused on New Positive Ischemic Heart Disease Efficacy Data for MANF in Animals
2. Amarantus BioSciences Wins MANF Patent Challenge in Europe
3. Amarantus BioSciences Issues CEO Letter to Shareholders
4. Amarantus BioSciences Secures $1.1 Million in Financing
5. Correction: Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
6. Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
7. Amarantus BioSciences Corporate Overview to be Webcast Live Today from OneMedForum 2012 Conference in NYC
8. TheStockRadio.com Interviews Amarantus BioSciences President & CEO Gerald E. Commissiong
9. Amarantus BioSciences Featured in BioWorld Today, Brewer Sports Symposium and Opportunist Magazine
10. Amarantus BioSciences to Present at the 2012 National Investment Banking Association Conference in New Orleans
11. IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014   Sequenom, Inc. (NASDAQ: ... innovative genetic analysis solutions, and Mayo Medical Laboratories ... in the United States , have ... and applications. "We have great appreciation for ... and we welcome the opportunity to partner with the ...
(Date:7/29/2014)... CITY, Md. , July 29, 2014 /PRNewswire/ ... announced a new and updated program for the ... 10 – 12, 2014 in Amelia Island ... CROs, sites and investigators remains unchanged, however, the ... purposeful exchange and networking opportunity among all stakeholders ...
(Date:7/29/2014)... Calif. , July 29, 2014 /PRNewswire-iReach/ -- ... agreement with FORMA Therapeutics, Inc., to provide access ... proprietary fragment-based lead discovery platform for novel small ... excited about the opportunity to work with FORMA ... of epigenetics and protein homeostasis. FORMA Therapeutics, decision ...
(Date:7/29/2014)... Rockville, MD (PRWEB) July 29, 2014 ... (ITI), a vaccine pioneer in the biotechnology industry, ... firm Newport Coast Securities, Inc. to explore financing ... commercializing LAMP-vax technology, a breakthrough vaccine platform with ... immunotherapy market. The company exclusively licensed the well-established ...
Breaking Biology Technology:Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 2TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 3Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3
... system, described as a breakthrough advancement in breast imaging, ... Drug Administration. , ,The system offers more evidence that ... tools that enable higher quality images for the detection ... GE Healthcare said the Senographe Essential system ...
... we asked William Yasnoff, founder of the eHealthTrust initiative, why ... that today are fractured and limited. , , ... William Yasnoff Yasnoff is a speaker at ... deliver a presentation titled "A New Patient-Centric and Sustainable Approach ...
... Madison, Wis. The Wisconsin Technology Council ... legislature with statewide membership arms, has announced eight additions ... have three-year terms and will join a board that ... business technology community. Electees include four technology organization leaders: ...
Cached Biology Technology:FDA approves advanced digital mammography system 2Interview: Dr. William Yasnoff on health records, part 2 2Interview: Dr. William Yasnoff on health records, part 2 3Interview: Dr. William Yasnoff on health records, part 2 4Interview: Dr. William Yasnoff on health records, part 2 5Interview: Dr. William Yasnoff on health records, part 2 6
(Date:7/28/2014)... of Medicine have pinpointed a mechanism in part of the ... blood, linking it to both type 1 and type 2 ... of Proceedings of the National Academies of Sciences . ... located in a part of the hypothalamus known as the ... that control glucose levels in the blood," said lead author ...
(Date:7/28/2014)... cure for Alzheimer,s disease and other forms of dementia, ... finding treatment. , University of Washington bioengineers have a ... changes of the body,s normal proteins into a state ... heart disease, Type 2 diabetes and Lou Gehrig,s disease. ... from their normal state into an abnormally folded form ...
(Date:7/28/2014)... Hospital study found that 73 percent of adult survivors ... developing metabolic syndrome and related health problems by failing ... the current issue of the journal Cancer . ... of childhood cancer in the study had metabolic syndrome, ... blood pressure, abdominal obesity, elevated triglyceride and other abnormalities ...
Breaking Biology News(10 mins):Glucose 'control switch' in the brain key to both types of diabetes 2New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3
... A Web site is a better source of information ... to a study of low-income mothers reported in the January ... http://www.jneb.org/) . Led by Kami J. Silk, Ph.D., of ... mothers with nutrition information in different formats. One group ...
... stars have understudies. Now, an increasingly popular radioactive ... by researchers at the National Institute of Standards ... medical imaging, speed up clinical trials of many ... medical treatment. The number of medical images ...
... knees on your list of New Year,s resolutions? ... wait longer to pursue knee-replacement surgery than men do. ... stand the pain, these women may also risk putting ... according to Lynn Snyder-Mackler, Distinguished Alumni Professor in UD,s ...
Cached Biology News:For nutrition info, moms like the Web best 2Radioactive 'understudy' may aid medical imaging, drug development 2Listen-up ladies: Don't postpone knee-replacement surgery 2Listen-up ladies: Don't postpone knee-replacement surgery 3
... The Guava PCA-96 systems provide automated, higher ... tray of microcentrifuge tubes. This flexible sample ... for screening in basic research, target validation, ... it's smaller cousin, the Guava PCA-96 uses ...
... delivers a novel procedure for the uniform ... whole genome DNA from small samples. This ... quick and highly reproducible amplification and labeling ... a REPLI-g Mini Kit module (QIAGEN) and ...
... The Cellomics KineticScan™ Reader ... provide "Smart Solutions for Cell-based ... you the ability to do ... analysis of physiological processes, dynamic ...
... Introduction of a protein into cells permits ... signaling pathways, apoptotic pathways, and transcription factor-mediated ... studying the effects of a specific protein ... the protein directly into the cell. ProteoJuice ...
Biology Products: